Primary Purpose
| primary_purpose | Study_Count |
|---|---|
| Treatment | 778 |
| Prevention | 98 |
| Diagnostic | 31 |
| Supportive Care | 27 |
| Other | 26 |
| Basic Science | 18 |
| NA | 15 |
| Health Services Research | 10 |
| Screening | 6 |
| Device Feasibility | 1 |
Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD
See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG
To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html
| Type | Study_count |
|---|---|
| Total_Studies | 1192 |
| interventional | 1010 |
| Observational | 163 |
| Registry | 19 |
```
| intervention_type | Study_Count |
|---|---|
| Drug | 267 |
| Drug|placebo | 192 |
| Device | 166 |
| Other | 89 |
| Procedure | 54 |
| Biological | 50 |
| Device|Other | 29 |
| Biological|placebo | 20 |
| Behavioral | 18 |
| Dietary Supplement | 14 |
| Drug|Other | 14 |
| Dietary Supplement|placebo | 13 |
| Device|Procedure | 11 |
| Biological|Other | 8 |
| Device|placebo | 7 |
| Drug|Procedure | 7 |
| Biological|Procedure | 6 |
| Other|placebo | 5 |
| Device|Drug | 4 |
| Biological|Drug | 3 |
| Dietary Supplement|Drug | 3 |
| Behavioral|Other | 2 |
| Combination Product|Other | 2 |
| Combination Product|Procedure | 2 |
| Diagnostic Test | 2 |
| Dietary Supplement|Other | 2 |
| Drug|Other|placebo | 2 |
| Drug|placebo|Procedure | 2 |
| Genetic|placebo | 2 |
| Behavioral|Device | 1 |
| Biological|Device|Drug|Procedure | 1 |
| Biological|Diagnostic Test|Drug | 1 |
| Biological|Drug|placebo | 1 |
| Combination Product | 1 |
| Device|Other|Procedure | 1 |
| Diagnostic Test|Drug | 1 |
| Diagnostic Test|Drug|Other | 1 |
| Dietary Supplement|Drug|placebo | 1 |
| Drug|Genetic | 1 |
| Drug|Other|Procedure | 1 |
| Genetic | 1 |
| Other|Procedure | 1 |
| placebo|Procedure | 1 |
| Country | Study_Count |
|---|---|
| United States | 271 |
| NA | 62 |
| France | 43 |
| China | 35 |
| Japan | 35 |
| United Kingdom | 35 |
| Canada | 28 |
| Denmark | 24 |
| Germany | 22 |
| Italy | 21 |
| Taiwan | 20 |
| Israel | 19 |
| United States|Canada | 15 |
| Korea, Republic of | 14 |
| Spain | 14 |
| Netherlands | 13 |
| India | 11 |
| Belgium | 9 |
| Iran, Islamic Republic of | 7 |
| Norway | 7 |
| Sweden | 7 |
| Australia | 6 |
| Mexico | 6 |
| Switzerland | 6 |
| Brazil | 5 |
| Egypt | 5 |
| Hong Kong | 5 |
| Singapore | 5 |
| United States|Canada|Puerto Rico | 5 |
| Thailand | 4 |
| United States|India | 4 |
| Finland | 3 |
| Pakistan | 3 |
| Russian Federation | 3 |
| Turkey | 3 |
| Austria|Belarus|Belgium|Canada|Czechia|France|Germany|Hungary|Italy|Poland|Serbia|Slovakia|Slovenia|Spain|Ukraine|United Kingdom | 2 |
| China|Korea, Republic of|Philippines|Taiwan | 2 |
| Czechia | 2 |
| Denmark|Sweden | 2 |
| Greece | 2 |
| Ireland | 2 |
| Jordan | 2 |
| United States|Argentina|Australia|Austria|Belarus|Belgium|Bosnia and Herzegovina|Brazil|Canada|Chile|China|Colombia|Croatia|Czechia|Egypt|Estonia|Finland|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Norway|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom | 2 |
| United States|Argentina|Australia|Austria|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Colombia|Croatia|Czechia|Estonia|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Lebanon|Lithuania|Mexico|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Switzerland|Turkey|Ukraine|United Kingdom | 2 |
| United States|Argentina|Australia|Austria|Belgium|Canada|China|Croatia|Czechia|Denmark|France|Germany|Hungary|India|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Poland|Romania|Russian Federation|Saudi Arabia|Serbia|Slovakia|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom | 2 |
| United States|Australia|Austria|Belgium|Bulgaria|Canada|Czechia|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Serbia|Slovakia|South Africa|Spain | 2 |
| United States|Bulgaria|Canada|Hungary|Latvia|Mexico|Poland|Russian Federation|Serbia|Switzerland|Ukraine | 2 |
| United States|Bulgaria|Georgia|Germany|Greece|Hungary|Ireland|Israel|Italy|Moldova, Republic of|Netherlands|Poland|Russian Federation|Serbia|Spain|Ukraine|United Kingdom | 2 |
| United States|Canada|Israel | 2 |
| United States|Puerto Rico | 2 |
| Argentina|Belgium|Brazil|Canada|Chile|Czech Republic|Estonia|Hungary|Italy|Russian Federation|Singapore|South Africa|Spain|Sweden | 1 |
| Australia|Belgium|Czech Republic|Denmark|France|Germany|Hungary|Israel|Italy|Poland|Russian Federation|South Africa|Spain|Sweden|United Kingdom | 1 |
| Australia|Belgium|Estonia|France|Israel|Italy|Latvia|Lithuania|Poland|Romania|Russian Federation|Slovakia|Sweden|Ukraine|United Kingdom | 1 |
| Australia|Bulgaria|Czechia|Estonia|Hungary|India|Italy|Korea, Republic of|Latvia|Malaysia|New Zealand|Poland|Romania|Russian Federation|Serbia|South Africa|Turkey|Ukraine | 1 |
| Australia|China|Korea, Republic of|Taiwan | 1 |
| Austria | 1 |
| Austria|Belgium|Canada|Czechia|Denmark|Finland|Germany|Greece|Italy|Lithuania|Norway|Poland|Russian Federation|Spain|Sweden|Ukraine|United Kingdom | 1 |
| Austria|Belgium|Canada|Czechia|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Netherlands|Norway|Portugal|Romania|Singapore|South Africa|Spain|Sweden|Switzerland|United Kingdom | 1 |
| Austria|Belgium|Denmark|France|Germany|Italy|Netherlands|Poland|Portugal|Spain|Switzerland|United Kingdom | 1 |
| Austria|Belgium|France|Germany|Netherlands | 1 |
| Austria|Belgium|France|Israel|Italy|Netherlands | 1 |
| Belarus | 1 |
| Belarus|India|Turkey|Ukraine | 1 |
| Belgium|Brazil|Chile|Czech Republic|Denmark|France|Hungary|Israel|Italy|Mexico|Netherlands|Poland|Slovakia|South Africa|Spain|Sweden|United Kingdom | 1 |
| Belgium|Bulgaria|Croatia|Denmark|Germany|Hungary|Netherlands|Poland|Slovakia|Sweden | 1 |
| Belgium|Canada|Germany|Norway|Sweden | 1 |
| Belgium|Czech Republic|Denmark|Finland|Germany|Netherlands|Norway|Sweden | 1 |
| Belgium|Czech Republic|Denmark|Germany|Norway|Slovakia|Spain | 1 |
| Belgium|Czech Republic|Germany|Hungary|Poland|Russian Federation | 1 |
| Belgium|Czech Republic|Latvia|Slovakia | 1 |
| Belgium|Finland | 1 |
| Belgium|Finland|France|Italy|Spain | 1 |
| Belgium|France | 1 |
| Belgium|France|Greece|Hungary|Poland|Spain | 1 |
| Belgium|France|Netherlands|United Kingdom | 1 |
| Belgium|Germany|Netherlands|United Kingdom | 1 |
| Belgium|Germany|United Kingdom | 1 |
| Belgium|Hungary|Netherlands | 1 |
| Belgium|Hungary|Slovakia|Spain | 1 |
| Belgium|Poland|Spain|United Kingdom | 1 |
| Belgium|United States|Argentina|Austria|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Denmark|Egypt|France|Germany|Greece|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|Slovenia|South Africa|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom | 1 |
| Benin | 1 |
| Bulgaria | 1 |
| Bulgaria|Czechia|Hungary|Latvia|Lithuania|Poland|Ukraine|United Kingdom | 1 |
| Bulgaria|Hungary|Poland | 1 |
| Bulgaria|United States|Argentina|Australia|Brazil|Colombia|Croatia|Czechia|Greece|Hungary|Latvia|Lithuania|Malaysia|New Zealand|Poland|Russian Federation|Turkey|Ukraine | 1 |
| Canada|Belgium|Netherlands|Sweden | 1 |
| Canada|Finland|Israel|Italy|Poland|Spain | 1 |
| Canada|Sweden|Ukraine|United States|Australia|Austria|Belgium|Bulgaria|Czech Republic|Denmark|France|Germany|Hungary|India|Israel|Japan|Lithuania|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa | 1 |
| Canada|United States|Australia|Belgium|Brazil|Czech Republic|France|Germany|India|Ireland|Italy|Korea, Republic of|Mexico|Netherlands|Poland|Puerto Rico|South Africa|Switzerland|United Kingdom | 1 |
| Central African Republic|Ghana | 1 |
| China|Hong Kong | 1 |
| China|Japan | 1 |
| China|Korea, Republic of | 1 |
| Colombia | 1 |
| Croatia|Poland|Romania|Russian Federation|Serbia|Spain | 1 |
| Cuba | 1 |
| Czech Republic | 1 |
| Czech Republic|France|Germany|Italy|Poland|United Kingdom | 1 |
| Czech Republic|France|Hungary|Italy | 1 |
| Czech Republic|Germany|Hungary|Romania|Russian Federation|Serbia | 1 |
| Czech Republic|Italy | 1 |
| Czechia|France|Germany|Hungary|Italy|Poland|United Kingdom | 1 |
| Czechia|France|Italy|Poland|Spain|United Kingdom | 1 |
| Czechia|France|Poland | 1 |
| Czechia|Netherlands|Poland | 1 |
| Denmark|Finland|Netherlands|Norway|Switzerland|United Kingdom | 1 |
| Denmark|France | 1 |
| Denmark|France|Germany|Poland|United Kingdom | 1 |
| Denmark|France|Germany|Spain | 1 |
| Denmark|Germany|Netherlands|Norway|Spain|United Kingdom | 1 |
| Denmark|Germany|Spain | 1 |
| Denmark|Germany|Sweden | 1 |
| Denmark|Korea, Republic of|United States|Australia|Austria|Belgium|Brazil|Canada|Colombia|Croatia|Czechia|Estonia|France|Germany|Hungary|Israel|Italy|Japan|Latvia|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Ukraine|United Kingdom | 1 |
| Denmark|Sweden|United Kingdom | 1 |
| Dominican Republic|Panama | 1 |
| France|Greece|Israel|Italy|Korea, Republic of|Serbia | 1 |
| France|Israel|Italy | 1 |
| France|United States|Belgium|Canada|Colombia|Czechia|Germany|Hungary|India|Ireland|Poland|Romania|South Africa|Spain|United Kingdom | 1 |
| Georgia|Germany|Moldova, Republic of|Ukraine | 1 |
| Georgia|Moldova, Republic of|Ukraine | 1 |
| Germany|Czech Republic|France|Netherlands | 1 |
| Germany|Israel|Netherlands|Singapore|Sweden|Switzerland|United Kingdom | 1 |
| Germany|Netherlands|Poland|United Kingdom | 1 |
| Germany|Poland | 1 |
| Germany|United Kingdom | 1 |
| Ghana | 1 |
| Hungary | 1 |
| Iceland | 1 |
| India|United States|Australia|Austria|Belgium|Bulgaria|Canada|Czech Republic|Denmark|France|Germany|Hungary|Israel|Japan|Latvia|Lithuania|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Sweden|Ukraine | 1 |
| Indonesia | 1 |
| Ireland|United Kingdom | 1 |
| Israel|Netherlands|Denmark|France|Germany|United States|Austria|Belgium|Canada|Poland | 1 |
| Israel|Slovakia|United States|Argentina|Australia|Belgium|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Croatia|Czechia|Denmark|Estonia|Germany|Hungary|Italy|Japan|Korea, Republic of|Lithuania|Mexico|Netherlands|Poland|Romania|Russian Federation|Serbia|Spain|Sweden|Turkey|Ukraine|United Kingdom | 1 |
| Israel|Spain | 1 |
| Israel|United States|Argentina|Australia|Belgium|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Croatia|Czechia|Denmark|Estonia|Germany|Hungary|Italy|Japan|Korea, Republic of|Lithuania|Mexico|Netherlands|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom | 1 |
| Italy|Lithuania|Poland|Russian Federation | 1 |
| Italy|Poland | 1 |
| Italy|Spain | 1 |
| Japan|United States|Argentina|Australia|Austria|Belgium|Bulgaria|Canada|Croatia|Czechia|France|Georgia|Germany|Greece|Hong Kong|Hungary|India|Ireland|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Netherlands|New Zealand|Norway|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Ukraine|United Kingdom | 1 |
| Japan|United States|Argentina|Australia|Austria|Belgium|Bulgaria|Canada|Croatia|Czechia|France|Georgia|Germany|Greece|Hong Kong|Hungary|India|Ireland|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Ukraine|United Kingdom | 1 |
| Lebanon | 1 |
| Netherlands|United Kingdom | 1 |
| New Zealand | 1 |
| Papua New Guinea | 1 |
| Poland | 1 |
| Poland|United Kingdom | 1 |
| Poland|United States|Argentina|Australia|Austria|Belgium|Canada|Czech Republic|Denmark|France|Germany|Hungary|Israel|New Zealand|Norway|Portugal|Spain|Switzerland | 1 |
| Portugal | 1 |
| South Africa | 1 |
| Sweden|United Kingdom | 1 |
| Ukraine|Austria|Belgium|Canada|Czech Republic|Denmark|Germany|Greece|Italy|Norway|Poland|Russian Federation|Sweden|United Kingdom | 1 |
| Ukraine|Czechia|France|Germany|Hungary|Poland|Russian Federation|Serbia|Spain|Sweden | 1 |
| Ukraine|United States|Australia|Belgium|Bulgaria|Canada|France|Germany|Hungary|Israel|Netherlands|Poland|Romania|Russian Federation | 1 |
| United States|Argentina|Australia|Austria|Belarus|Belgium|Bulgaria|Canada|Croatia|Czechia|Georgia|Germany|Greece|Hungary|Israel|Italy|Korea, Republic of|Latvia|Moldova, Republic of|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Ukraine|United Kingdom | 1 |
| United States|Argentina|Australia|Austria|Belarus|Belgium|Bulgaria|Canada|Croatia|Czechia|Georgia|Germany|Greece|Hungary|Israel|Italy|Korea, Republic of|Latvia|Moldova, Republic of|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Ukraine|United Kingdom | 1 |
| United States|Argentina|Australia|Austria|Belgium|Bosnia and Herzegovina|Brazil|Canada|Chile|China|Colombia|Croatia|Czechia|Egypt|Estonia|Finland|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Norway|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom | 1 |
| United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Colombia|Croatia|Czechia|Denmark|Estonia|France|Germany|India|Greece|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Norway|Philippines|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Turkey|Ukraine|United Kingdom|Vietnam | 1 |
| United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Czechia|Denmark|France|Germany|Greece|Hungary|United Kingdom|Israel|Italy|Korea, Republic of|Lithuania|Mexico|Netherlands|Poland|Romania|Spain|Switzerland | 1 |
| United States|Argentina|Australia|Austria|Belgium|Canada|Croatia|Czechia|Denmark|France|Georgia|Germany|Hungary|India|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Moldova, Republic of|Netherlands|Poland|Romania|Russian Federation|Saudi Arabia|Serbia|Slovakia|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom | 1 |
| United States|Argentina|Australia|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Colombia|Croatia|Czechia|Denmark|Estonia|France|Germany|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Mexico|Netherlands|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|Spain|Taiwan|Turkey|Ukraine|United Kingdom | 1 |
| United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|China|Czechia|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Netherlands|Poland|Portugal|Romania|Russian Federation|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom | 1 |
| United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|Czech Republic|Denmark|France|Germany|Hungary|India|Korea, Republic of|Mexico|Netherlands|New Zealand|Peru|Poland|Portugal|Romania|Russian Federation|Singapore|South Africa|Spain|Sweden|Taiwan|United Kingdom | 1 |
| United States|Argentina|Australia|Brazil|Bulgaria|Estonia|France|Hong Kong|Mexico|Poland|Russian Federation|Serbia|Slovakia|Ukraine | 1 |
| United States|Argentina|Australia|Brazil|Germany|Mexico|Poland|Russian Federation|Ukraine | 1 |
| United States|Argentina|Australia|Bulgaria|Canada|Czech Republic|Finland|Germany|Indonesia|Korea, Republic of|Mexico|Norway|Philippines|Poland|Portugal|Romania|Russian Federation|Slovakia|South Africa|Thailand | 1 |
| United States|Argentina|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Denmark|Egypt|France|Germany|Greece|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Poland|Sweden|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Singapore|Slovakia|Slovenia|South Africa|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom | 1 |
| United States|Argentina|Austria|Brazil|Canada|Czechia|Denmark|Germany|Hungary|Italy|Poland|Slovakia|Spain | 1 |
| United States|Argentina|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Colombia|Estonia|Greece|Hungary|Ireland|Japan|Korea, Republic of|Lebanon|Mexico|New Zealand|Portugal|Slovakia|Spain|Switzerland|Turkey|Ukraine | 1 |
| United States|Australia | 1 |
| United States|Australia|Austria|Belgium|Brazil|Canada|Colombia|Croatia|Czech Republic|Denmark|Estonia|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Latvia|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Ukraine|United Kingdom | 1 |
| United States|Australia|Austria|Belgium|Brazil|Canada|Colombia|Croatia|Czech Republic|Denmark|Estonia|France|Germany|Hungary|Israel|Korea, Republic of|Latvia|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Ukraine|United Kingdom | 1 |
| United States|Australia|Austria|Belgium|Brazil|Canada|France|Germany|Hungary|Italy|Mexico|Netherlands|Poland|South Africa | 1 |
| United States|Australia|Austria|Belgium|Bulgaria|Canada|Czechia|Denmark|France|Germany|Hungary|Israel|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|Ukraine|United Kingdom | 1 |
| United States|Australia|Austria|Belgium|Bulgaria|Canada|Czechia|France|Germany|Hungary|Israel|Korea, Republic of|Latvia|Lithuania|New Zealand|Poland|Romania|Russian Federation|Spain|Ukraine|United Kingdom | 1 |
| United States|Australia|Austria|Belgium|Bulgaria|Canada|Czechia|France|Germany|Hungary|Israel|Latvia|Lithuania|New Zealand|Poland|Romania|Spain|Ukraine|United Kingdom | 1 |
| United States|Australia|Austria|Belgium|Canada|Colombia|Croatia|Czech Republic|Denmark|Estonia|France|Germany|Hungary|Israel|Italy|Japan|Latvia|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Ukraine|United Kingdom | 1 |
| United States|Australia|Austria|Belgium|Canada|Czechia|Denmark|Estonia|France|Germany|Greece|Hungary|Italy|Latvia|Netherlands|Norway|Poland|Russian Federation|Switzerland|United Kingdom | 1 |
| United States|Australia|Austria|Belgium|Canada|Czechia|Hungary|Israel|Japan|New Zealand|Poland|Slovakia|Spain|United Kingdom | 1 |
| United States|Australia|Austria|Brazil|Croatia|Czechia|Germany|Israel|Italy|Japan|Lithuania|Netherlands|Poland|Romania|Russian Federation|Serbia|South Africa|United Kingdom | 1 |
| United States|Australia|Belarus|Belgium|Bulgaria|Canada|Chile|Croatia|Czechia|Denmark|Estonia|France|Georgia|Germany|Hungary|India|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Moldova, Republic of|Netherlands|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Thailand|Turkey|Ukraine|United Kingdom | 1 |
| United States|Australia|Belarus|Belgium|Bulgaria|Canada|Chile|Croatia|Czechia|Estonia|Georgia|Hungary|India|Italy|Korea, Republic of|Latvia|Moldova, Republic of|Poland|Russian Federation|Serbia|Slovakia|South Africa|Spain|Ukraine | 1 |
| United States|Australia|Belarus|Bulgaria|Canada|Chile|Colombia|Croatia|Czech Republic|Denmark|Finland|Germany|Hungary|India|Italy|Poland|Russian Federation|Ukraine | 1 |
| United States|Australia|Belgium|Bulgaria|Canada|Greece|Hungary|Israel|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Slovakia|Ukraine | 1 |
| United States|Australia|Belgium|Canada|Czech Republic|Germany|Hungary|Israel|New Zealand|Spain|United Kingdom | 1 |
| United States|Australia|Belgium|Canada|Czechia|Denmark|France|Georgia|Hungary|Japan|Lithuania|Moldova, Republic of|Netherlands|Poland|Romania|United Kingdom | 1 |
| United States|Australia|Belgium|Canada|Czechia|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Poland|Russian Federation|United Kingdom | 1 |
| United States|Australia|Belgium|Canada|Czechia|Germany|Hungary|Israel|Korea, Republic of|Malaysia | 1 |
| United States|Australia|Belgium|Canada|Czechia|Germany|Hungary|Israel|New Zealand|Spain|United Kingdom | 1 |
| United States|Australia|Belgium|Germany|Israel|Italy|Korea, Republic of|Saudi Arabia|Serbia|Spain|Turkey | 1 |
| United States|Australia|Bulgaria|Canada|Czechia|France|Germany|Hungary|Italy|Netherlands|New Zealand|Poland|Russian Federation|Ukraine | 1 |
| United States|Australia|Bulgaria|Canada|France|Georgia|Germany|Greece|Hungary|Israel|Japan|Korea, Republic of|Poland|Portugal|Serbia|Slovakia|South Africa|Spain|Taiwan|Ukraine | 1 |
| United States|Australia|Bulgaria|Hungary|Italy|Japan|Poland|Russian Federation|Slovakia|Spain|Thailand|Turkey | 1 |
| United States|Australia|New Zealand|South Africa | 1 |
| United States|Australia|Poland|Slovakia|United Kingdom | 1 |
| United States|Austria|Belgium|Canada|Czech Republic|Germany|Hungary|Italy|Netherlands|Poland|Puerto Rico|Slovakia|Sweden | 1 |
| United States|Austria|Belgium|Canada|Czechia|Denmark|France|Germany|Hungary|Israel|Italy|Japan|Netherlands|Poland|Romania|Slovakia|Spain|Switzerland|Ukraine|United Kingdom | 1 |
| United States|Austria|Belgium|Canada|Germany|Greece|Italy|Japan|Korea, Republic of|Netherlands|Poland|Russian Federation|Spain|United Kingdom | 1 |
| United States|Austria|Belgium|Canada|Germany|Italy|Japan|Korea, Republic of|Poland|Russian Federation|Spain|United Kingdom | 1 |
| United States|Austria|Bulgaria|Canada|Czechia|Denmark|Georgia|Germany|Hungary|Israel|Italy|Korea, Republic of|Poland|Romania|Russian Federation|Serbia|Slovakia|Spain|Turkey|Ukraine | 1 |
| United States|Austria|Bulgaria|Canada|France|Germany|Hungary|Netherlands|Poland|Romania|Spain | 1 |
| United States|Austria|Canada|France|Germany|Italy|Switzerland|United Kingdom | 1 |
| United States|Austria|Estonia|Germany|Poland|South Africa|Sweden|United Kingdom | 1 |
| United States|Belarus|Bosnia and Herzegovina|Bulgaria|Croatia|Czechia|Netherlands|North Macedonia|Poland|Portugal|Romania|Russian Federation|Serbia|Spain|Ukraine|United Kingdom | 1 |
| United States|Belarus|Bosnia and Herzegovina|Croatia|Georgia|Hungary|Moldova, Republic of|Poland|Russian Federation|Serbia|Ukraine | 1 |
| United States|Belarus|Bulgaria|Canada|France|Germany|Hungary|Ireland|Israel|Italy|Poland|Romania|Russian Federation|Serbia|Spain|Ukraine|United Kingdom | 1 |
| United States|Belarus|Canada|Croatia|Czech Republic|Estonia|Hungary|Latvia|Lithuania|Poland|Puerto Rico|Romania|Russian Federation|Serbia|Ukraine | 1 |
| United States|Belgium|Brazil|France|Israel|Italy|Korea, Republic of|Netherlands|Poland|Spain|Taiwan | 1 |
| United States|Belgium|Bulgaria|Canada|Czech Republic|France|Germany|Hungary|Netherlands|Poland|Russian Federation|Ukraine | 1 |
| United States|Belgium|Canada | 1 |
| United States|Belgium|Canada|Czechia|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Serbia|Slovakia|South Africa|Spain|Ukraine|United Kingdom | 1 |
| United States|Belgium|Canada|Denmark|Netherlands | 1 |
| United States|Belgium|Canada|France|Germany|Hungary|Israel|Netherlands|Poland|Ukraine|United Kingdom | 1 |
| United States|Belgium|Canada|France|Hungary|Israel|Netherlands|Poland|Ukraine|United Kingdom | 1 |
| United States|Belgium|Canada|Germany|Hungary|Italy|Slovakia|Sweden | 1 |
| United States|Belgium|Canada|Germany|Netherlands|United Kingdom | 1 |
| United States|Belgium|Canada|Hungary | 1 |
| United States|Belgium|Canada|Hungary|Moldova, Republic of|Netherlands|Romania | 1 |
| United States|Belgium|Czech Republic|India|Poland|Russian Federation|Slovakia|Ukraine|United Kingdom | 1 |
| United States|Belgium|Italy|Korea, Republic of|Netherlands|Poland | 1 |
| United States|Brazil|Canada|Czechia|Denmark|Germany|Hungary|India|Israel|Italy|Mexico|Poland|Slovakia|South Africa|Ukraine | 1 |
| United States|Bulgaria|Canada|Czechia|Estonia|France|India|Korea, Republic of|Netherlands|Poland|Russian Federation|Serbia|Slovakia|South Africa|Ukraine|United Kingdom | 1 |
| United States|Bulgaria|Canada|Czechia|Estonia|Hungary|Latvia|Lithuania|Poland|Russian Federation|Ukraine | 1 |
| United States|Bulgaria|Canada|Hungary|Poland|Slovakia | 1 |
| United States|Canada|Croatia|Poland|Romania | 1 |
| United States|Canada|Czech Republic|Hungary|Latvia|Romania|Russian Federation|Ukraine | 1 |
| United States|Canada|Czech Republic|Hungary|Poland|Russian Federation|Slovakia | 1 |
| United States|Canada|Czechia|Hungary|Netherlands|Poland|Serbia | 1 |
| United States|Canada|France|Germany|Hungary|Italy|Korea, Republic of|Netherlands|Spain|United Kingdom | 1 |
| United States|Canada|Hungary|Israel|Poland|Slovakia|United Kingdom | 1 |
| United States|Canada|India|Mexico | 1 |
| United States|Canada|Israel|Japan|Korea, Republic of | 1 |
| United States|Canada|United Kingdom | 1 |
| United States|China | 1 |
| United States|China|Poland|Puerto Rico|Ukraine | 1 |
| United States|Czechia|Hungary | 1 |
| United States|Czechia|Hungary|Poland|Romania|Russian Federation|Serbia | 1 |
| United States|Denmark|Finland|Ireland|Israel|Slovenia|United Kingdom | 1 |
| United States|Denmark|Germany|Poland | 1 |
| United States|Denmark|Hungary|Italy|Spain|United Kingdom | 1 |
| United States|Estonia|Germany|Poland|South Africa|United Kingdom | 1 |
| United States|Georgia|Hungary|Moldova, Republic of|Ukraine | 1 |
| United States|Georgia|Moldova, Republic of | 1 |
| United States|Germany | 1 |
| United States|Germany|Netherlands|Poland|Russian Federation|Sweden|United Kingdom | 1 |
| United States|Germany|United Kingdom | 1 |
| United States|India|Nepal | 1 |
| United States|Japan|Poland|Slovakia|Spain|United Kingdom | 1 |
| United States|Lithuania|Poland|Slovakia | 1 |
| United States|Netherlands Antilles | 1 |
| United States|New Zealand | 1 |
| United States|Russian Federation|Ukraine | 1 |
| Uruguay | 1 |
| Vietnam | 1 |
| Zambia | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 505 |
| 2 | 69 |
| 3 | 49 |
| 4 | 21 |
| 5 | 18 |
| 6 | 16 |
| 7 | 20 |
| 8 | 15 |
| 9 | 7 |
| 10 | 6 |
| 11 | 9 |
| 12 | 9 |
| 13 | 7 |
| 14 | 3 |
| 15 | 10 |
| 16 | 7 |
| 17 | 6 |
| 18 | 4 |
| 19 | 6 |
| 20 | 6 |
| 21 | 2 |
| 22 | 8 |
| 23 | 6 |
| 24 | 3 |
| 25 | 7 |
| 26 | 5 |
| 27 | 4 |
| 28 | 5 |
| 29 | 1 |
| 30 | 5 |
| 31 | 2 |
| 32 | 3 |
| 33 | 7 |
| 34 | 5 |
| 35 | 2 |
| 36 | 2 |
| 37 | 3 |
| 38 | 3 |
| 39 | 2 |
| 40 | 1 |
| 41 | 2 |
| 42 | 1 |
| 43 | 3 |
| 44 | 2 |
| 45 | 3 |
| 47 | 1 |
| 49 | 1 |
| 50 | 3 |
| 51 | 1 |
| 52 | 2 |
| 55 | 1 |
| 56 | 1 |
| 57 | 1 |
| 58 | 3 |
| 59 | 2 |
| 60 | 2 |
| 61 | 1 |
| 62 | 3 |
| 63 | 3 |
| 64 | 5 |
| 65 | 1 |
| 66 | 2 |
| 68 | 2 |
| 69 | 1 |
| 70 | 1 |
| 71 | 2 |
| 72 | 2 |
| 75 | 1 |
| 76 | 3 |
| 77 | 2 |
| 78 | 1 |
| 80 | 1 |
| 81 | 2 |
| 82 | 1 |
| 86 | 1 |
| 88 | 3 |
| 89 | 1 |
| 90 | 2 |
| 92 | 1 |
| 93 | 1 |
| 94 | 1 |
| 95 | 1 |
| 96 | 1 |
| 97 | 2 |
| 99 | 2 |
| 102 | 2 |
| 104 | 1 |
| 105 | 5 |
| 108 | 2 |
| 111 | 1 |
| 114 | 1 |
| 115 | 1 |
| 117 | 1 |
| 119 | 1 |
| 120 | 1 |
| 123 | 1 |
| 125 | 1 |
| 126 | 1 |
| 134 | 1 |
| 135 | 1 |
| 136 | 1 |
| 142 | 1 |
| 144 | 1 |
| 150 | 1 |
| 166 | 1 |
| 173 | 2 |
| 174 | 1 |
| 178 | 1 |
| 182 | 1 |
| 190 | 1 |
| 192 | 1 |
| 195 | 1 |
| 207 | 1 |
| 208 | 1 |
| 210 | 1 |
| 245 | 2 |
| 253 | 1 |
| 262 | 1 |
| 275 | 1 |
| 298 | 1 |
| 305 | 1 |
| 307 | 1 |
| 309 | 1 |
| 323 | 1 |
| 330 | 1 |
| 343 | 1 |
| 372 | 2 |
| 378 | 1 |
| 382 | 1 |
| 409 | 1 |
| 433 | 1 |
| 435 | 1 |
| 463 | 1 |
| 516 | 1 |
| 524 | 1 |
| 586 | 1 |
| 590 | 1 |
| 855 | 1 |
| Phase | Study_Count |
|---|---|
| N/A | 347 |
| Phase 3 | 209 |
| Phase 2 | 190 |
| Phase 4 | 103 |
| Phase 1 | 78 |
| Phase 1/Phase 2 | 43 |
| Phase 2/Phase 3 | 33 |
| Early Phase 1 | 7 |
| Number_of_Arms | Count_of_Studies |
|---|---|
| 1 | 187 |
| 2 | 546 |
| 3 | 118 |
| 4 | 37 |
| 5 | 22 |
| 6 | 10 |
| 7 | 2 |
| 8 | 3 |
| 10 | 4 |
| 12 | 1 |
| 14 | 1 |
| 16 | 1 |
| NA | 78 |
| Measure | Early.Phase.1 | N.A | Phase.1 | Phase.1.Phase.2 | Phase.2 | Phase.2.Phase.3 | Phase.3 | Phase.4 |
|---|---|---|---|---|---|---|---|---|
| Min. | 12.0 | 3.0 | 3.00000 | 3.00000 | 1.0000 | 15.0000 | 13.0000 | 1.0000 |
| 1st Qu. | 16.0 | 30.0 | 13.75000 | 19.00000 | 43.0000 | 62.0000 | 149.7500 | 52.5000 |
| Median | 50.0 | 68.0 | 24.00000 | 34.00000 | 88.0000 | 142.0000 | 326.0000 | 118.0000 |
| Mean | 39.0 | 288326.2 | 35.37179 | 76.30233 | 117.0374 | 321.0303 | 421.4904 | 487.8544 |
| 3rd Qu. | 59.5 | 143.5 | 47.00000 | 60.00000 | 171.0000 | 408.0000 | 521.7500 | 204.5000 |
| Max. | 60.0 | 99999999.0 | 181.00000 | 1100.00000 | 462.0000 | 2000.0000 | 3384.0000 | 30024.0000 |
| group_type | Group_Count |
|---|---|
| Experimental | 1109 |
| Active Comparator | 450 |
| Placebo Comparator | 303 |
| Other | 112 |
| NA | 78 |
| No Intervention | 68 |
| Sham Comparator | 29 |
| intervention_model | Study_Count |
|---|---|
| Parallel Assignment | 730 |
| Single Group Assignment | 224 |
| Crossover Assignment | 33 |
| NA | 11 |
| Sequential Assignment | 10 |
| Factorial Assignment | 2 |
| primary_purpose | Study_Count |
|---|---|
| Treatment | 778 |
| Prevention | 98 |
| Diagnostic | 31 |
| Supportive Care | 27 |
| Other | 26 |
| Basic Science | 18 |
| NA | 15 |
| Health Services Research | 10 |
| Screening | 6 |
| Device Feasibility | 1 |
| Country | Study_Count |
|---|---|
| United States | 41 |
| France | 13 |
| NA | 13 |
| Japan | 12 |
| China | 11 |
| Korea, Republic of | 8 |
| Canada | 6 |
| Denmark | 4 |
| Spain | 4 |
| United Kingdom | 4 |
| United States|Canada | 4 |
| Germany | 3 |
| Austria | 2 |
| Belgium | 2 |
| Czech Republic | 2 |
| Norway | 2 |
| Russian Federation | 2 |
| Sweden | 2 |
| United States|Italy | 2 |
| Brazil | 1 |
| Côte D’Ivoire | 1 |
| Canada|Germany|Ireland|Italy|Netherlands|Poland|Sweden|United Kingdom | 1 |
| Colombia | 1 |
| Croatia | 1 |
| Denmark|France|United States|Argentina|Australia|Austria|Belgium|Canada|Czechia|Germany|Israel|Netherlands|New Zealand|Switzerland|United Kingdom | 1 |
| Egypt | 1 |
| France|Greece|Italy | 1 |
| Greece | 1 |
| Hong Kong|Singapore|Taiwan | 1 |
| Indonesia | 1 |
| Ireland | 1 |
| Israel | 1 |
| Italy | 1 |
| Netherlands | 1 |
| Portugal | 1 |
| Romania | 1 |
| Saudi Arabia | 1 |
| Singapore | 1 |
| Switzerland | 1 |
| Syrian Arab Republic | 1 |
| Taiwan|Argentina|China|Colombia|Korea, Republic of|Mexico|Russian Federation|Saudi Arabia|Singapore|Turkey | 1 |
| Tunisia | 1 |
| United States|Australia|Austria|Belgium|Canada|Croatia|Denmark|France|Germany|Greece|Ireland|Israel|Italy|Mexico|Netherlands|New Zealand|Norway|Puerto Rico|Spain|Sweden|United Kingdom | 1 |
| United States|Austria|Belgium|Canada|Croatia|Denmark|Estonia|France|Germany|Greece|Ireland|Israel|Italy|Netherlands|Norway|Portugal|Slovenia|Spain|Sweden|Switzerland|United Kingdom | 1 |
| United States|Austria|Canada|Czechia|France|Germany|Greece|Italy|Korea, Republic of|Spain | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 115 |
| 2 | 5 |
| 3 | 5 |
| 4 | 3 |
| 5 | 1 |
| 6 | 1 |
| 8 | 1 |
| 11 | 1 |
| 12 | 3 |
| 15 | 3 |
| 19 | 1 |
| 21 | 1 |
| 23 | 1 |
| 24 | 1 |
| 26 | 1 |
| 30 | 3 |
| 31 | 1 |
| 36 | 1 |
| 46 | 1 |
| 47 | 2 |
| 60 | 1 |
| 61 | 1 |
| 63 | 1 |
| 76 | 1 |
| 80 | 1 |
| 103 | 1 |
| 105 | 1 |
| 108 | 1 |
| 149 | 1 |
| 159 | 1 |
| 287 | 1 |
| 515 | 1 |
| Measure | Observational |
|---|---|
| Min | 1.0000 |
| 1st Qu | 59.0000 |
| Median | 146.0000 |
| Mean | 870.5092 |
| 3rd Qu | 501.5000 |
| Max | 39000.0000 |
| observational_model | Study_Count |
|---|---|
| Cohort | 103 |
| Case-Only | 25 |
| Case-Control | 11 |
| Other | 9 |
| Case Control | 7 |
| NA | 5 |
| Case-Crossover | 2 |
| Ecologic or Community | 1 |
| time_perspective | Study_Count |
|---|---|
| Prospective | 124 |
| Retrospective | 21 |
| Cross-Sectional | 13 |
| Other | 5 |
| Country | Study_Count |
|---|---|
| United States | 9 |
| Netherlands | 2 |
| Canada | 1 |
| Czechia | 1 |
| Germany | 1 |
| Greece | 1 |
| Korea, Republic of | 1 |
| Norway | 1 |
| Spain | 1 |
| United States|Canada | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 12 |
| 2 | 2 |
| 3 | 1 |
| 13 | 1 |
| 14 | 1 |
| 15 | 1 |
| 37 | 1 |
| Measure | Registries |
|---|---|
| Min | 50.00 |
| 1st Qu | 260.00 |
| Median | 800.00 |
| Mean | 11979.74 |
| 3rd Qu | 5500.00 |
| Max | 175000.00 |
| observational_model | Study_Count |
|---|---|
| Cohort | 11 |
| Case-Only | 4 |
| Other | 3 |
| Case-Control | 1 |
| time_perspective | Study_Count |
|---|---|
| Prospective | 17 |
| Cross-Sectional | 1 |
| Other | 1 |
| target_duration | Study_Count |
|---|---|
| 5 Years | 4 |
| 1 Month | 3 |
| 1 Year | 2 |
| 2 Years | 2 |
| 1 Day | 1 |
| 12 Months | 1 |
| 24 Weeks | 1 |
| 25 Years | 1 |
| 3 Months | 1 |
| 4 Months | 1 |
| 5 Months | 1 |
| 6 Months | 1 |
#If less then 500 trials
#If less then 500 studies
| nct_id | brief_title | link | overall_status | source | primary_completion_date |
|---|---|---|---|---|---|
| NCT02578004 | Risk Factors for Pressure Ulcers | https://ClinicalTrials.gov/show/NCT02578004 | Completed | Centre Hôpital Universitaire Farhat Hached | 2014-04-30 |
| NCT02438410 | Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT02438410 | Completed | Mayo Clinic | 2019-12-04 |
| NCT01688258 | New Multiplex Real-time PCR for Genital Ulcer Disease | https://ClinicalTrials.gov/show/NCT01688258 | Completed | University of Zurich | 2013-07-31 |
| NCT03939000 | Clinical Profile and Laboratory Finding of DFU From Tertiary Hospitals in Bali | https://ClinicalTrials.gov/show/NCT03939000 | Completed | Udayana University | 2018-12-31 |
| NCT03370237 | Reliability of a Diabetic Foot Ulcer Risk Stratification and Referral Algorithm | https://ClinicalTrials.gov/show/NCT03370237 | Completed | Lawson Health Research Institute | 2017-09-22 |
| NCT03824561 | Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis] | https://ClinicalTrials.gov/show/NCT03824561 | Recruiting | Takeda | 2022-01-31 |
| NCT03341559 | Spatial Frequency Domain Imaging (SFD) for Assessment of Diabetic Foot Ulcer Development and Healing | https://ClinicalTrials.gov/show/NCT03341559 | Completed | University of Southern California | 2019-12-31 |
| NCT03223012 | Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service | https://ClinicalTrials.gov/show/NCT03223012 | Completed | AbbVie | 2019-02-28 |
| NCT03214952 | Drug Use Surveillance of Vonoprazan for “Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis” | https://ClinicalTrials.gov/show/NCT03214952 | Completed | Takeda | 2018-10-31 |
| NCT03214198 | Special Drug Use Surveillance of Takecab for “Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use” | https://ClinicalTrials.gov/show/NCT03214198 | Completed | Takeda | 2020-04-30 |
| NCT03214094 | Special Drug Use Surveillance of Vonoprazan for “Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use” | https://ClinicalTrials.gov/show/NCT03214094 | Completed | Takeda | 2019-02-28 |
| NCT03179865 | Evaluation of Early Mucosal Healing During Clinical Remission in Pediatric Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT03179865 | Completed | Wolfson Medical Center | 2020-02-29 |
| NCT03167632 | Oral Ulcer Prevalence: Hospital-based Cross-sectional Study | https://ClinicalTrials.gov/show/NCT03167632 | Completed | Cairo University | 2015-10-25 |
| NCT03163680 | Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers | https://ClinicalTrials.gov/show/NCT03163680 | Completed | Damascus Hospital | 2018-05-01 |
| NCT03142113 | Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT03142113 | Completed | Universitaire Ziekenhuizen Leuven | 2016-12-31 |
| NCT03090139 | Sub-optimal Response to Anti-Tumor Necrosis Factor’s in Inflammatory Bowel Disease in Emerging Markets | https://ClinicalTrials.gov/show/NCT03090139 | Completed | Takeda | 2018-06-13 |
| NCT03086577 | Pain in Chronic Leg- and Foot Ulcers | https://ClinicalTrials.gov/show/NCT03086577 | Recruiting | University College of Southeast Norway | 2018-02-21 |
| NCT03070938 | PuraPlyâ„¢ Antimicrobial Wound Matrix and Wound Management | https://ClinicalTrials.gov/show/NCT03070938 | Completed | Organogenesis | 2017-09-30 |
| NCT03070925 | Prospective PuraPlyâ„¢ AM Case Series Study | https://ClinicalTrials.gov/show/NCT03070925 | Completed | Organogenesis | 2017-04-30 |
| NCT03063138 | Evaluation of 3D Imaging Ulcer Camera | https://ClinicalTrials.gov/show/NCT03063138 | Completed | Odense University Hospital | 2017-03-01 |
| NCT03060733 | Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects | https://ClinicalTrials.gov/show/NCT03060733 | Completed | DiaSorin Inc. | 2018-05-14 |
| NCT03057171 | A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA | https://ClinicalTrials.gov/show/NCT03057171 | Recruiting | Yonsei University | 2020-04-30 |
| NCT02986724 | A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD) | https://ClinicalTrials.gov/show/NCT02986724 | Active, not recruiting | Takeda | 2020-08-31 |
| NCT02904707 | Interest of Skin Graft Pellets in the Management of Ulcers Algic | https://ClinicalTrials.gov/show/NCT02904707 | Completed | Groupe Hospitalier Paris Saint Joseph | 2015-05-31 |
| NCT02889913 | When Asking the Indication of a Skin Biopsy From a Patient With a Leg Ulcer in Primary Care? | https://ClinicalTrials.gov/show/NCT02889913 | Completed | Groupe Hospitalier Paris Saint Joseph | 2015-07-31 |
| NCT02868398 | Efficacy of Golimumab in Maintaining Deep Remission in UC Patients in Prolonged Remission With Infliximab | https://ClinicalTrials.gov/show/NCT02868398 | Completed | Evangelismos Hospital | 2020-04-30 |
| NCT02838251 | Effects of Compression in Mixed Ulcers | https://ClinicalTrials.gov/show/NCT02838251 | Completed | Groupe Hospitalier Paris Saint Joseph | 2016-07-31 |
| NCT02808780 | An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT02808780 | Recruiting | Janssen Biotech, Inc. | 2031-07-30 |
| NCT02717897 | Vitamin D and Disease Activity in Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT02717897 | Completed | University of Chicago | 2013-05-31 |
| NCT02693730 | Phenotyping IBS: Perceptions and Modulations of Visceral Sensations | https://ClinicalTrials.gov/show/NCT02693730 | Active, not recruiting | University of California, Los Angeles | 2020-08-31 |
| NCT02674308 | Entyvio (Vedolizumab) Long Term Safety Study | https://ClinicalTrials.gov/show/NCT02674308 | Active, not recruiting | Takeda | 2021-07-22 |
| NCT02640391 | Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT02640391 | Completed | Kyungpook National University Hospital | 2018-12-31 |
| NCT02586259 | Effectiveness of Cortiment® in Patients With Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT02586259 | Completed | Ferring Pharmaceuticals | 2018-04-05 |
| NCT00001184 | Immune Regulation in Ulcerative Colitis or Crohn s Disease | https://ClinicalTrials.gov/show/NCT00001184 | Recruiting | National Institutes of Health Clinical Center (CC) | NA |
| NCT03404557 | Proteomic Analysis of Crohn’s Disease Macrophages in Response or Not to AIEC | https://ClinicalTrials.gov/show/NCT03404557 | Completed | University Hospital, Clermont-Ferrand | 2019-01-18 |
| NCT02738125 | Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions | https://ClinicalTrials.gov/show/NCT02738125 | Active, not recruiting | AbbVie | 2028-11-20 |
| NCT02506179 | Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT02506179 | Completed | AbbVie | 2020-02-10 |
| NCT02502552 | Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort | https://ClinicalTrials.gov/show/NCT02502552 | Completed | Centre Hospitalier Universitaire de Saint Etienne | 2015-10-31 |
| NCT02499263 | A Prospective Non-interventional Multicenter Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in Routine Clinical Practice | https://ClinicalTrials.gov/show/NCT02499263 | Completed | AbbVie | 2018-09-17 |
| NCT02439372 | Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT02439372 | Completed | Asan Medical Center | 2016-06-30 |
| NCT02423512 | The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness | https://ClinicalTrials.gov/show/NCT02423512 | Completed | Icahn School of Medicine at Mount Sinai | 2017-06-13 |
| NCT02423187 | Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin | https://ClinicalTrials.gov/show/NCT02423187 | Completed | Eisai Inc. | 2017-10-30 |
| NCT02316990 | China Survey of Stress Ulcer Bleeding in Critically Ill Neurosurgical Patients | https://ClinicalTrials.gov/show/NCT02316990 | Completed | AstraZeneca | 2015-07-31 |
| NCT02274714 | Dysmenorrhea in Women With Crohn’s Disease and Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT02274714 | Completed | University of Wisconsin, Madison | 2017-01-31 |
| NCT02229344 | Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea | https://ClinicalTrials.gov/show/NCT02229344 | Active, not recruiting | Janssen Korea, Ltd., Korea | 2022-02-22 |
| NCT02149043 | Thermography in Surveillance of Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT02149043 | Completed | University Hospital Dubrava | 2018-01-31 |
| NCT02110862 | Scintigraphic Evaluation of IPAA Function in Patients With Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT02110862 | Completed | Odense University Hospital | 2013-08-31 |
| NCT02099708 | Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs | https://ClinicalTrials.gov/show/NCT02099708 | Completed | Takeda | 2014-03-31 |
| NCT02099682 | Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin | https://ClinicalTrials.gov/show/NCT02099682 | Completed | Takeda | 2014-01-31 |
| NCT01301976 | Nutritional State and Intake Nutrients Assessment in Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT01301976 | Completed | UPECLIN HC FM Botucatu Unesp | 2010-03-31 |
| NCT01285973 | Evaluation of Integra® Artificial Dermis for the Treatment of Leg Ulcers | https://ClinicalTrials.gov/show/NCT01285973 | Completed | Integra LifeSciences Services | 2015-08-31 |
| NCT01282905 | Hydrogen Sulfide Detoxification and Butyrate Metabolism in Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT01282905 | Completed | KU Leuven | NA |
| NCT01278550 | Prevention of Recurrent Ulcer Bleeding in High-risk Users of Low-dose Aspirin | https://ClinicalTrials.gov/show/NCT01278550 | Completed | Chinese University of Hong Kong | 2013-03-31 |
| NCT02632929 | Prevention of Amputation in Diabetic Foot Ulcers Using Amniotic Tissue | https://ClinicalTrials.gov/show/NCT02632929 | Active, not recruiting | Boise VA Medical Center | 2019-07-31 |
| NCT02054533 | Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease | https://ClinicalTrials.gov/show/NCT02054533 | Completed | Icahn School of Medicine at Mount Sinai | 2017-06-30 |
| NCT01960439 | Responsiveness of Endoscopic Evaluation in UC | https://ClinicalTrials.gov/show/NCT01960439 | Completed | University of Western Ontario, Canada | 2015-07-31 |
| NCT01947816 | Special Investigation in Patients With Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT01947816 | Completed | AbbVie | 2018-02-15 |
| NCT01916161 | The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease Patients | https://ClinicalTrials.gov/show/NCT01916161 | Completed | National Health Service, United Kingdom | 2016-02-29 |
| NCT01891214 | Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn’s Disease | https://ClinicalTrials.gov/show/NCT01891214 | Completed | Rennes University Hospital | 2016-04-30 |
| NCT01888588 | Risk of Uncomplicated Peptic Ulcer in the General Population | https://ClinicalTrials.gov/show/NCT01888588 | Completed | AstraZeneca | 2013-05-31 |
| NCT01852760 | Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound | https://ClinicalTrials.gov/show/NCT01852760 | Completed | Lawson Health Research Institute | 2015-07-31 |
| NCT01848561 | A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) | https://ClinicalTrials.gov/show/NCT01848561 | Recruiting | AbbVie | 2027-04-06 |
| NCT01814943 | The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users | https://ClinicalTrials.gov/show/NCT01814943 | Completed | AstraZeneca | 2013-05-31 |
| NCT01798953 | Surgical Reconstruction in Ulcerative Colitis With Primary Sclerosing Cholangitis | https://ClinicalTrials.gov/show/NCT01798953 | Completed | Sahlgrenska University Hospital, Sweden | 2013-02-28 |
| NCT01768858 | Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn’s Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice | https://ClinicalTrials.gov/show/NCT01768858 | Completed | AbbVie | 2017-08-13 |
| NCT01729182 | Nexium Capsules LDA Specific Clinical Experience Investigation | https://ClinicalTrials.gov/show/NCT01729182 | Completed | AstraZeneca | 2017-03-09 |
| NCT01705522 | Multimodal Approach in IBD Patients | https://ClinicalTrials.gov/show/NCT01705522 | Recruiting | Clinical Hospital Colentina | 2019-09-30 |
| NCT01678300 | Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC) | https://ClinicalTrials.gov/show/NCT01678300 | Completed | Beth Israel Deaconess Medical Center | 2015-11-30 |
| NCT01654783 | Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA | https://ClinicalTrials.gov/show/NCT01654783 | Completed | Kyorin Pharmaceutical Co.,Ltd | 2014-06-30 |
| NCT01594658 | Venous Ulcer Treatment With Foam Versus Conservative Treatment | https://ClinicalTrials.gov/show/NCT01594658 | Completed | Hospital Occidente de Kennedy | 2012-02-29 |
| NCT01591486 | Helicobacter Pylori and the Long-term Risk of Peptic Ulcer Bleeding | https://ClinicalTrials.gov/show/NCT01591486 | Completed | Chinese University of Hong Kong | 2013-02-28 |
| NCT01562600 | Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation | https://ClinicalTrials.gov/show/NCT01562600 | Completed | AstraZeneca | 2015-08-27 |
| NCT01551667 | Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds | https://ClinicalTrials.gov/show/NCT01551667 | Completed | Centre Hospitalier Universitaire de NÄ«mes | 2016-03-31 |
| NCT01517607 | Mesalazine (PENTASA®) in Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT01517607 | Completed | Ferring Pharmaceuticals | 2013-12-31 |
| NCT01517594 | Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT01517594 | Completed | Ferring Pharmaceuticals | 2013-06-30 |
| NCT01468090 | Disease Course in an IBD Cohort in the Era of Biological Treatment | https://ClinicalTrials.gov/show/NCT01468090 | Completed | Hvidovre University Hospital | 2014-06-30 |
| NCT01467609 | PillCam Colon Capsule Endoscopy for Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT01467609 | Completed | Shanghai Jiao Tong University School of Medicine | 2010-07-31 |
| NCT01435525 | Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation | https://ClinicalTrials.gov/show/NCT01435525 | Completed | AstraZeneca | 2014-03-31 |
| NCT01434485 | Nexium Capsules Clinical Experience Investigation | https://ClinicalTrials.gov/show/NCT01434485 | Completed | AstraZeneca | 2014-03-31 |
| NCT01387698 | Prospective, Longitudinal Multicentric Survey in the Therapeutic Care of Mild to Moderate Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT01387698 | Completed | Ferring Pharmaceuticals | 2015-10-31 |
| NCT01363453 | User Surveillance in Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT01363453 | Completed | Ferring Pharmaceuticals | 2008-05-31 |
| NCT04447170 | Laparoscopic Versus Open Repair of Peptic Ulcer Perforation | https://ClinicalTrials.gov/show/NCT04447170 | Enrolling by invitation | University of Roma La Sapienza | 2020-12-31 |
| NCT04272307 | MIcroorganisms as Triggers in Acute Severe Ulcerative Colitis and Their Influence on Medical Therapy Efficacy: a Multi-omics Pilot Approach. | https://ClinicalTrials.gov/show/NCT04272307 | Recruiting | University Hospital, Bordeaux | 2021-02-28 |
| NCT04249661 | Differential Effects of Bacteria Colonising Venous Leg Ulcers on Pain and Healing Rates | https://ClinicalTrials.gov/show/NCT04249661 | Recruiting | University Hospital of Limerick | 2021-01-09 |
| NCT03416049 | The Effects of Pulsed Elelectro-Magnetic Fields (“PEMF”) in the Treatment of Venous Stasis Leg Ulcers | https://ClinicalTrials.gov/show/NCT03416049 | Recruiting | PEMF Systems, Inc. | 2020-06-01 |
| NCT04211194 | Registry for Upper Gastrointestinal Bleeding | https://ClinicalTrials.gov/show/NCT04211194 | Recruiting | AdventHealth | 2020-12-31 |
| NCT04197973 | Association Between Self-reported Web-based SCCAI and Health-related Quality of Life Index in UC Patients | https://ClinicalTrials.gov/show/NCT04197973 | Recruiting | Keimyung University Dongsan Medical Center | 2020-06-20 |
| NCT04148274 | A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT04148274 | Recruiting | ProgenaBiome | 2023-03-31 |
| NCT04131530 | Automatic Evaluation of Inflammation Activity in Ulcerative Colitis Using pCLE With Artificial Intelligence | https://ClinicalTrials.gov/show/NCT04131530 | Recruiting | Shandong University | 2019-12-31 |
| NCT03955289 | Treatment of Foot and Leg Ulcers Using a Laser | https://ClinicalTrials.gov/show/NCT03955289 | Completed | University of Texas Southwestern Medical Center | 2019-01-30 |
| NCT03952364 | The PRECIOUS Study: Predicting Crohn’s & ColitIs Outcomes in the United States | https://ClinicalTrials.gov/show/NCT03952364 | Recruiting | PredictImmune Ltd | 2021-06-30 |
| NCT03952195 | Complications and Outcomes of Pouch Excision | https://ClinicalTrials.gov/show/NCT03952195 | Completed | Icahn School of Medicine at Mount Sinai | 2017-04-01 |
| NCT03947931 | Russian Extremely Severe Ulcerative Colitis Study | https://ClinicalTrials.gov/show/NCT03947931 | Recruiting | State Scientific Centre of Coloproctology, Russian Federation | 2021-06-20 |
| NCT03942861 | Sonographic Assessment in Severe Ulcerative Colitis Patients Admitted for Intravenous Corticosteroids and Eligible for Infliximab Rescue Therapy; a Prospective Clinician-blinded Observational Study Protocol. | https://ClinicalTrials.gov/show/NCT03942861 | Recruiting | Copenhagen University Hospital at Herlev | 2020-08-21 |
| NCT03907631 | Multi-centre Acute Severe Ulcerative Colitis Prospective Cohort Study (Elevate ASUC) | https://ClinicalTrials.gov/show/NCT03907631 | Recruiting | Hull University Teaching Hospitals NHS Trust | 2020-09-01 |
| NCT03912467 | Prevalence of Pressure Ulcers Among Critically Ill Patients and Factors Associated With Their Occurrence in the ICU | https://ClinicalTrials.gov/show/NCT03912467 | Completed | French Society for Intensive Care | 2017-06-01 |
| NCT03884439 | Infliximab Biosimilar “Pfizer” Drug Use Investigation (Crohn’s Disease or Ulcerative Colitis) | https://ClinicalTrials.gov/show/NCT03884439 | Recruiting | Pfizer | 2023-03-13 |
| NCT03839680 | Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT03839680 | Recruiting | Centre Hospitalier Universitaire de Besancon | 2019-04-15 |
| NCT03808506 | Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT03808506 | Recruiting | Lawson Health Research Institute | 2021-06-30 |
| NCT03802214 | Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF（Tumor Necrosis Factor）Therapy | https://ClinicalTrials.gov/show/NCT03802214 | Recruiting | Stanford University | 2021-12-31 |
| NCT03788824 | Evaluation of Inflammation Activity in Ulcerative Colitis by pCLE | https://ClinicalTrials.gov/show/NCT03788824 | Recruiting | Shandong University | 2018-12-31 |
| NCT03782727 | ObservAtional Study to Investigate Surgical Site Infection in Ulcerated Skin Cancers | https://ClinicalTrials.gov/show/NCT03782727 | Completed | Cardiff and Vale University Health Board | 2020-05-31 |
| NCT03773445 | Golimumab Trough Levels in Patients With Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT03773445 | Recruiting | Hospital San Carlos, Madrid | 2019-10-31 |
| NCT03765450 | Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT03765450 | Recruiting | Robarts Clinical Trials Inc. | 2019-12-31 |
| NCT03747068 | The Influence of Biologcal Treatment on the Short-Term Complications of Surgery in Patients With Inflematory Bowel Disease. | https://ClinicalTrials.gov/show/NCT03747068 | Completed | HaEmek Medical Center, Israel | 2015-10-09 |
| NCT03710486 | A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn’s Disease (CD) Participants | https://ClinicalTrials.gov/show/NCT03710486 | Recruiting | Takeda | 2021-09-30 |
| NCT03698812 | A Multicenter Prospective Cohort Study on the Clinical Prognosis of Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT03698812 | Recruiting | Nanfang Hospital of Southern Medical University | 2020-09-30 |
| NCT03689673 | Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC) | https://ClinicalTrials.gov/show/NCT03689673 | Active, not recruiting | Ipsen | 2020-12-31 |
| NCT03669822 | Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC) | https://ClinicalTrials.gov/show/NCT03669822 | Recruiting | Johns Hopkins University | 2020-12-31 |
| NCT03643211 | Xeljanz Special Investigation for Long-term Use in UC Patients | https://ClinicalTrials.gov/show/NCT03643211 | Active, not recruiting | Pfizer | 2022-01-05 |
| NCT03589183 | Gut Microbiome in Inflammatory Bowel Disease | https://ClinicalTrials.gov/show/NCT03589183 | Recruiting | Kyunghee University Medical Center | 2028-03-31 |
| NCT03578692 | Indicators Predicting Surgery in Acute Severe Ulcerative Colitis(ASUC) | https://ClinicalTrials.gov/show/NCT03578692 | Completed | Nanjing PLA General Hospital | 2018-01-31 |
| NCT03549988 | Pro-active Fecal Calprotectin Monitoring PROMOTE-UC | https://ClinicalTrials.gov/show/NCT03549988 | Recruiting | University of British Columbia | 2020-06-30 |
| NCT03501758 | Predicting Relapse of Ulcerative Colitis With Gastrointestinal Ultrasound | https://ClinicalTrials.gov/show/NCT03501758 | Recruiting | Haukeland University Hospital | 2023-12-30 |
| NCT01376414 | H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department | https://ClinicalTrials.gov/show/NCT01376414 | Completed | George Washington University | 2014-08-31 |
| NCT03460847 | Fecal Microbiota Alterations in Steroid Refractory Active Colitis Ulcerosa | https://ClinicalTrials.gov/show/NCT03460847 | Recruiting | Medical University of Graz | 2020-03-31 |
| NCT03452501 | Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients | https://ClinicalTrials.gov/show/NCT03452501 | Active, not recruiting | Hikma Pharmaceuticals LLC | 2020-06-30 |
| NCT03440528 | Using of Irradiated Amnion Dressing for the Treatment of Skin Ulcer | https://ClinicalTrials.gov/show/NCT03440528 | Completed | Egyptian Atomic Energy Authority | 2018-09-30 |
| NCT01199536 | Helicobacter Pylori Eradication Treatment in Patients With Duodenal Ulcers | https://ClinicalTrials.gov/show/NCT01199536 | Completed | AstraZeneca | 2013-11-30 |
| NCT01169207 | Johns Hopkins Crohn’s Disease and Ulcerative Colitis Study | https://ClinicalTrials.gov/show/NCT01169207 | Active, not recruiting | Johns Hopkins University | 2020-12-31 |
| NCT01274767 | Prevention of Recurrent Ulcer Bleeding in High-risk Aspirin Users Who Are Not Infected With Helicobacter Pylori | https://ClinicalTrials.gov/show/NCT01274767 | Completed | Chinese University of Hong Kong | 2010-06-30 |
| NCT01104753 | A Study of Pentasa in Patients With Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT01104753 | Completed | Ferring Pharmaceuticals | 2010-10-31 |
| NCT01091558 | Study of Effects of L-Arginine in Colitis and Colon Cancer | https://ClinicalTrials.gov/show/NCT01091558 | Completed | Vanderbilt University Medical Center | 2011-12-31 |
| NCT01041196 | Perforated Marginal Ulcer After Gastric Bypass | https://ClinicalTrials.gov/show/NCT01041196 | Completed | University of California, San Francisco | 2009-01-31 |
| NCT01040416 | Endoscopic Therapy for Bleeding Marginal Ulcers After Gastric Bypass | https://ClinicalTrials.gov/show/NCT01040416 | Completed | University of California, San Francisco | 2009-12-31 |
| NCT01032525 | Monroe County Inflammatory Bowel Disease (IBD) Registry | https://ClinicalTrials.gov/show/NCT01032525 | Completed | University of Rochester | 2013-05-31 |
| NCT01041079 | Chronic Marginal Ulcers After Gastric Bypass | https://ClinicalTrials.gov/show/NCT01041079 | Completed | University of California, San Francisco | 2009-12-31 |
| NCT00961948 | Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT00961948 | Completed | Mayo Clinic | 2013-02-28 |
| NCT00917514 | An Investigational Study to Test Usability of the Electronic Dosing Equipment Medicpen | https://ClinicalTrials.gov/show/NCT00917514 | Completed | Medicpen AB | 2010-02-28 |
| NCT00900029 | Safety Follow-Up to HP 802-247-09-015 | https://ClinicalTrials.gov/show/NCT00900029 | Completed | Healthpoint | 2011-10-31 |
| NCT03479242 | Diabetic Foot Ulcer Recurrence: Pilot Study | https://ClinicalTrials.gov/show/NCT03479242 | Recruiting | Indiana University | 2021-12-31 |
| NCT04075669 | Multiplex Strip Polymerase Chain Reaction for Diagnosis of Eye Infection Diseases From Corneal Scraping Samples | https://ClinicalTrials.gov/show/NCT04075669 | Recruiting | Fakultas Kedokteran Universitas Indonesia | 2020-06-30 |
| NCT03957447 | Treat Early and Broad: Thermotherapy of Buruli Ulcer Integrated Into WHOrecommended Wound Management in West Africa | https://ClinicalTrials.gov/show/NCT03957447 | Recruiting | University Hospital Heidelberg | 2021-06-01 |
| NCT03827902 | Diabetic Foot Ulcer and Wound Infection | https://ClinicalTrials.gov/show/NCT03827902 | Recruiting | University of Texas Southwestern Medical Center | 2020-05-31 |
| NCT03863054 | An Observational Clinical Trial Examining the Effect of Topical Oxygen Therapy (NATROXâ„¢) on the Rates of Healing of Chronic Diabetic Foot Ulcers | https://ClinicalTrials.gov/show/NCT03863054 | Recruiting | Singapore General Hospital | 2020-06-30 |
| NCT03060746 | Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects | https://ClinicalTrials.gov/show/NCT03060746 | Completed | DiaSorin Inc. | 2018-05-03 |
| NCT02577120 | Wound Healing Endpoint and Recurrence | https://ClinicalTrials.gov/show/NCT02577120 | Recruiting | Indiana University | 2020-12-31 |
| NCT02581098 | miR-200b & miR-21 in Diabetic Wounds | https://ClinicalTrials.gov/show/NCT02581098 | Recruiting | Indiana University | 2020-12-31 |
| NCT02261636 | Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment | https://ClinicalTrials.gov/show/NCT02261636 | Completed | Ferring Pharmaceuticals | 2019-01-14 |
| NCT02245802 | Multicenter Validation on Predicting Mortality for Patients With Bleeding Peptic Ulcers | https://ClinicalTrials.gov/show/NCT02245802 | Completed | Chinese University of Hong Kong | 2012-04-30 |
| NCT02170207 | Takepron Intravenous 30 mg Specified Drug-use Survey [Acute Stress Ulcer and Acute Gastric Mucosal Lesions] | https://ClinicalTrials.gov/show/NCT02170207 | Completed | Takeda | 2010-03-31 |
| NCT01241266 | China Survey of Peptic Ulcer Bleeding | https://ClinicalTrials.gov/show/NCT01241266 | Completed | AstraZeneca | 2011-07-31 |
| NCT03535649 | A Study to Assess Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis (UC) Korean Participants | https://ClinicalTrials.gov/show/NCT03535649 | Completed | Takeda | 2018-12-18 |
| NCT00780507 | Fecal Biomarker Study for Patients With Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT00780507 | Completed | Warner Chilcott | 2009-07-31 |
| NCT00759889 | Obtaining and Storing Standard of Care Wound Biopsies for Immediate or Future Wound-Related Scientific Study | https://ClinicalTrials.gov/show/NCT00759889 | Completed | Southwest Regional Wound Care Center | 2018-12-30 |
| NCT00710489 | Potential Research Study Participant Registry | https://ClinicalTrials.gov/show/NCT00710489 | Completed | University of California, Davis | 2018-09-05 |
| NCT00709631 | Interest of a Systematic Biopsy for Hard-to-heal Leg Ulcers | https://ClinicalTrials.gov/show/NCT00709631 | Completed | Assistance Publique - Hôpitaux de Paris | 2009-06-30 |
| NCT00705484 | European Safety Registry in Ulcerative Colitis (P04808) | https://ClinicalTrials.gov/show/NCT00705484 | Completed | Merck Sharp & Dohme Corp. | 2016-10-20 |
| NCT00617916 | Hyperspectral Imaging to Assess and Predict Diabetic Foot Ulcers | https://ClinicalTrials.gov/show/NCT00617916 | Completed | HyperMed | 2008-09-30 |
| NCT00604422 | Evaluation of the PillCamâ„¢ Colon Capsule Endoscopy (PCCE) in Detection & Classification of Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT00604422 | Completed | Medtronic - MITG | 2010-02-28 |
| NCT00606346 | A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease | https://ClinicalTrials.gov/show/NCT00606346 | Active, not recruiting | Janssen Biotech, Inc. | 2037-11-15 |
| NCT00587236 | Compare Conventional Colonosocpy to Endoscopic AFI, NBI for Dysplasia Detection for Ulcerative Colitis & Cholangitis | https://ClinicalTrials.gov/show/NCT00587236 | Completed | Mayo Clinic | 2010-08-31 |
| NCT00522002 | CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study | https://ClinicalTrials.gov/show/NCT00522002 | Completed | George Washington University | 2010-06-30 |
| NCT00474097 | Follow-Up Phone Calls After Colorectal Surgery | https://ClinicalTrials.gov/show/NCT00474097 | Completed | University Hospitals Cleveland Medical Center | 2007-12-31 |
| NCT00463619 | Follow-up Study With Retarded Release Phosphatidylcholine in Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT00463619 | Completed | Heidelberg University | 2010-04-30 |
| NCT00403923 | Amount of Lactose Causing Symptoms in People With Lactose Intolerance and Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT00403923 | Completed | University Hospitals, Leicester | 2007-06-30 |
| NCT00405834 | A Pilot Study of the Envision® Surface | https://ClinicalTrials.gov/show/NCT00405834 | Completed | Hill-Rom | NA |
| NCT00405795 | Envision® Surface Evaluation | https://ClinicalTrials.gov/show/NCT00405795 | Completed | Hill-Rom | NA |
| NCT00274209 | Chromoendoscopy for Ulcerative Colitis Surveillance | https://ClinicalTrials.gov/show/NCT00274209 | Completed | Indiana University | 2011-11-30 |
| NCT00222378 | Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease | https://ClinicalTrials.gov/show/NCT00222378 | Completed | University of Miami | 2012-06-30 |
| NCT00207688 | A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients | https://ClinicalTrials.gov/show/NCT00207688 | Completed | Janssen Research & Development, LLC | 2015-09-09 |
| NCT00153712 | Natural History of Non-steroidal Anti-inflammatory Drug and Non-Helicobacter Pylori in Bleeding Peptic Ulcers | https://ClinicalTrials.gov/show/NCT00153712 | Completed | Chinese University of Hong Kong | 2009-07-31 |
| NCT00013286 | A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk | https://ClinicalTrials.gov/show/NCT00013286 | Completed | VA Office of Research and Development | NA |
#If less then 500 registries
| nct_id | brief_title | link | overall_status | source | primary_completion_date |
|---|---|---|---|---|---|
| NCT03251118 | A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease | https://ClinicalTrials.gov/show/NCT03251118 | Recruiting | Target PharmaSolutions, Inc. | 2025-07-31 |
| NCT03824418 | The Clinical Value of Chromoendoscopy as Surveillance Strategy for Dysplasia Detection in Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT03824418 | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2018-05-09 |
| NCT03367897 | Bleeding Ulcer and Erosions Study “BLUE Study” | https://ClinicalTrials.gov/show/NCT03367897 | Completed | Ostfold Hospital Trust | 2017-12-31 |
| NCT03286452 | The RESPOND Registry | https://ClinicalTrials.gov/show/NCT03286452 | Completed | Organogenesis | 2018-07-15 |
| NCT02813161 | The Diabetic Foot Ulcer Registry | https://ClinicalTrials.gov/show/NCT02813161 | Recruiting | U.S. Wound Registry | 2025-01-31 |
| NCT02813187 | Venous Leg Ulcer and Lymphedema Registry | https://ClinicalTrials.gov/show/NCT02813187 | Enrolling by invitation | U.S. Wound Registry | 2025-05-31 |
| NCT02798055 | Bosentan Treatment of Digital Ulcers Related to Systemic Sclerosis | https://ClinicalTrials.gov/show/NCT02798055 | Completed | Elpen Pharmaceutical Co. Inc. | 2019-06-30 |
| NCT02463500 | UT Southwestern Diabetic Foot Ulcers (DFU) and Osteomyelitis (DFO) Recruitment Database, Data and Tissue Repository | https://ClinicalTrials.gov/show/NCT02463500 | Recruiting | University of Texas Southwestern Medical Center | 2021-01-31 |
| NCT02326155 | To Evaluate the Safety and Efficacy of Remsimaâ„¢ in Patients With Crohn’s Disease (CD) or Ulcerative Colitis (UC) | https://ClinicalTrials.gov/show/NCT02326155 | Recruiting | Celltrion | 2020-06-30 |
| NCT02308917 | Canadian Children Inflammatory Bowel Disease Network (CIDsCANN) | https://ClinicalTrials.gov/show/NCT02308917 | Recruiting | The Hospital for Sick Children | 2023-12-31 |
| NCT02280733 | A Real World, Observational Registry of Chronic Wounds and Ulcers | https://ClinicalTrials.gov/show/NCT02280733 | Recruiting | U.S. Wound Registry | 2025-01-31 |
| NCT03257254 | Effect of VarIthena on Wound Healing in Venous Leg Ulcers (VLU) | https://ClinicalTrials.gov/show/NCT03257254 | Active, not recruiting | Provensis Ltd | 2020-05-31 |
| NCT02152904 | Risk Factors of Rebleeding After Peptic Ulcer Bleeding: a Nationwide Cohort Study | https://ClinicalTrials.gov/show/NCT02152904 | Completed | Incheon St.Mary’s Hospital | 2015-12-31 |
| NCT02130349 | IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD. | https://ClinicalTrials.gov/show/NCT02130349 | Recruiting | Maastricht University Medical Center | 2020-12-31 |
| NCT02047084 | Comparison of Human Allograft to Apligraf for Venous Leg Ulcers | https://ClinicalTrials.gov/show/NCT02047084 | Enrolling by invitation | Solsys Medical LLC | 2019-12-31 |
| NCT04032756 | Tofacitinib Registry of Patients With Ulcerative Colitis in Germany | https://ClinicalTrials.gov/show/NCT04032756 | Recruiting | Ced Service GmbH | 2023-03-31 |
| NCT03872726 | Development and Validation of a Self-reported Objective Index of Work Disability in Inflammatory Bowel Disease | https://ClinicalTrials.gov/show/NCT03872726 | Recruiting | Corporacion Parc Tauli | 2019-05-30 |
| NCT03772145 | Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study | https://ClinicalTrials.gov/show/NCT03772145 | Enrolling by invitation | University of North Carolina, Chapel Hill | 2020-12-31 |
| NCT03884634 | Efficacy of the Dabir Surfaces Micropressure Overlay for Decubitus Ulcer Prevention During Cardiac Surgery | https://ClinicalTrials.gov/show/NCT03884634 | Recruiting | The Cleveland Clinic | 2021-02-28 |